RemeGen (09995) Announces Monthly Equity Movements and Public Float Status

Bulletin Express03-04

RemeGen (09995) released a monthly update for the period ended 28 February 2026, reporting no changes in its overall share structure. The total authorized and registered share capital stood at 564.48 million shares, each with a par value of RMB1.

H shares (Stock Code: 09995), listed on The Stock Exchange of Hong Kong, remained at 208.58 million issued shares, with no treasury shares. The public float requirement was confirmed to be in compliance.

A shares (Stock Code: 688331), listed on the Shanghai Stock Exchange, remained at 355.90 million in authorized and registered shares. Of these, 355.70 million were in issue, and 0.19 million were held in treasury. No new shares were issued, and no treasury shares were canceled or transferred during the month.

Three A Share Incentive Schemes were noted, but no additional shares were issued in February 2026. The total number of shares that may be issued under these schemes stood at 2.32 million. The figures above reflect no material movements in issued or treasury shares for the reporting month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment